Skip to content
Home/Companies/MedTech/Optos

Optos

MedTech·UK·Exited 2015
Entry
–
Hold
–
Exit
2015

Who owns Optos?

Optos was owned by Amadeus Capital Partners through Amadeus II Technology Fund (2000 vintage), exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-28

Amadeus Capital Partners
Investor
Amadeus Capital Partners
Amadeus II Technology Fund · 2000

Key facts

HQUK
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2015

More from Amadeus II Technology Fund

Other portfolio companies in the same fund.

Openbravo
Openbravo
Exited 2022
SaaSSpain· 2008
to
Icera
Exited 2011
Deep TechUK· 2006
to
Forescout
Exited 2017
CybersecurityUS· 2005
Aepona
Exited 2013
SoftwareUK· 2003
to
Ciphergen Biosystems
Exited 2000
BiotechUS· 2000

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Optos

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Optos?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Optos.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue